Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. 2007

Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
Department of Microbiology and Molecular Biology, National JALMA Institute for Leprosy and Other Mycobacterial Diseases (ICMR), Tajganj, Agra (Uttar Pradesh) 282001, India.

Pyrazinamide (PZA) is an important first-line antituberculosis drug because of its sterilizing activity against semidormant tubercle bacilli. In spite of its very high in vivo activity, its in vitro activity is not apparent unless an acidic environment is available, which makes PZA susceptibility testing difficult by conventional methods. The present study was, therefore, planned to assess the performance of the colorimetric BacT/ALERT 3D system and compare the results with those from conventional tests, i.e., the Löwenstein-Jensen (LJ) proportion method (pH 4.85) and Wayne's pyrazinamidase (PZase) assay, using 107 clinical isolates. The concordance among all of these tests was 89.71% after the first round of testing and reached 92.52% after resolution of the discordant results by retesting. Prolonged incubation of the PZase tube for up to 10 days was found to increase the specificity of the PZase test. The concordances between LJ proportion and BacT/ALERT 3D, LJ proportion and the PZase assay, and BacT/ALERT 3D and the PZase assay were found to be 99.06%, 93.46%, and 92.52%, respectively. Using the LJ results as the gold standard, the sensitivities of BacT/ALERT 3D and the PZase assay were 100 and 82.85%, respectively, while the specificity was 98.61% for both of the tests. The difference between the sensitivities of BacT/ALERT 3D and the PZase assay was significant (P = 0.025). The mean turnaround times for the detection of resistant and susceptible results by BacT/ALERT 3D were 8.04 and 11.32 days, respectively. While the major limitations associated with the PZase assay and the LJ proportion method are lower sensitivity in previously treated patients and a longer time requirement, respectively, the BacT/ALERT 3D system was found to be rapid, highly sensitive, and specific.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011718 Pyrazinamide A pyrazine that is used therapeutically as an antitubercular agent. Tisamid
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000581 Amidohydrolases Any member of the class of enzymes that catalyze the cleavage of amide bonds and result in the addition of water to the resulting molecules. Amidases,Amidohydrolase
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
November 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
September 1995, Journal of clinical microbiology,
Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
July 2010, The Indian journal of medical research,
Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
December 2000, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
October 2011, Mikrobiyoloji bulteni,
Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
June 2006, Journal of clinical microbiology,
Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
April 2001, Diagnostic microbiology and infectious disease,
Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
July 2019, Laboratory medicine,
Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
September 2007, The Journal of antimicrobial chemotherapy,
Pushpendra Singh, and Clement Wesley, and G P S Jadaun, and Sunil Kumar Malonia, and R Das, and P Upadhyay, and J Faujdar, and P Sharma, and P Gupta, and Abhay Kumar Mishra, and Kalpana Singh, and D S Chauhan, and V D Sharma, and U D Gupta, and K Venkatesan, and V M Katoch
January 2007, Pneumologia (Bucharest, Romania),
Copied contents to your clipboard!